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 Doxorubicin antibiotic produced by Streptomyces peucetius is a very crucial antibiotic with a large 
spectrum used as an anticancer drug and in clinical treatment. Production of doxorubicin from wild type strain 
by microbiological fermentation process is nomally very low yield and limited. The enhancement of 
doxorubicin production (DXR) by the genetically engineering of the auxiliary genes involved in the pathway of 
doxorubicin biosynthesis from Streptomyces peucetius has being focused by many research groups. The gene 
cluster responsible for biosynthesis of doxorubicin had been isolated, sequenced and characterized. Among 
them, the dnrQ and dnrS genes belong to the gene cluster encoded for the glycosyltransferase and helper 
enzymes, which are responsible for attachment of sugar moiety to -rhodomycinon intermediate and regulation 
of doxorubicin production, respectively. In this research, the dnrQ and dnrS genes were isolated and cloned in 
the p25.1 vector containing the strong promoter (ermE*) to generate the p25.1QS as a recombinant vector. The 
obtained plasmid was transferred into the host strain Streptomyces peucetius MH9.2 by the protoplast 
transformation method to generate the S. peucetius MH9.2SQ strain. Doxorubicin production from the 
recombinant S. peucetius MH9.2SQ and the parent strain were extracted and purified by using chlorofrom and 
methanol solvents. The products were confirmed by HPLC, LC-mass analysis and antibacterial bioassay. The 
results showed that the over production of doxorubicin was accumulated by the recombinant strain from the 
fermentation broth. In the S. peucetius MH9.2SQ, the doxorubicin productivity was 3.1 to 3.6 folds higher than 
in the parent strain. This recombinant strain could be a potential candidate for further research in enhancement 
and larger biomass scale of DXR production.  
Keywords: Doxorubicin production,gene cloning, MH9.2SQ strain, Streptomyces peucetius.   
INTRODUCTION 
 Doxorubicin (DXR) (adriamycin or 14-
hydroxydaunorubicin) is an anthracycline antibiotic 
produced from Streptomyces peucetius ATCC 27952 
and used in chemotherapy for treatment of various 
cancers. DXR was first isolated and studied by the 
Arcamone group (Arcamone et al., 1997). The wild 
type strain is nomaly to produce very low yield (2 
mg.l-1) due to very toxic compound and it causes the 
death for host cell (Mallar et al., 2010).  To improve 
the production of doxorubicin, many researchers 
have had efforts to study the biosynthesis pathway 
and the gene regulation for higher yield of DXR by 
genetical modification and recombinant methods of 
wild type strain. Many of the published studies on 
the enhancement of secondary metabolites have 
focused either on the over expression of one positive 
regulator or by the deletion of one negative regulator 
at a time. Two classes of regulatory genes were 
reported as pathway specific and global regulatory 
involved in the production of secondary metabolites 
(Chater et al., 1996). Some other regulatory genes 
generally located outside the biosynthetic gene 
cluster may play a regulatory role in the cluster 
showing effects on the production of multiple 
secondary metabolites. Over expression of regulators 
increase the production of different secondary 
metabolites such as actinorhodin in S. coelicolor by 
actII-orf4 and redD (Narva et al., 1990; Fernández-
Moreno et al., 1991), nikkomycin in S. 
ansochromogenes by sanG (Liu et al., 2005), 
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clavulanic acid in S. clavuligerus by ccaR (Hung et 
al., 2007).  
 Doxorubicin biosynthesis gene cluster had been 
isolated and sequenced, among them the dnrS and 
dnrQ genes play a very crucial role for the post 
biosynthesis doxorubicin as glycosylation step. The 
gene dnrS encodes for glycosytransferase and is 
responsible for the attachment of deoxysugar 2,3,6-
trideoxy-3-aminohexose, daunosamine to the 
rhodomycinone core (Dreier et al., 2007; Jiang et 
al., 2006). The gene dnrQ encodes the auxiliary 
protein to help the activity of DnrS and for the 
complement of DnrQ/S activity (Singh et al., 2010) 
(Fig. 1). In addition, glycosyltransferase and 
auxiliary gene have thought to act as regulator for 
the enhancement of production. The expression of 
dnrS or dnrQ separately had not given any positive 
regulation for the DRX production. However, the 
over expression together of dnrS/Q led to 
remarkably increase the DRX amount in the S. 
peucetius host cells via in vivo experiment (Sharee 














 The aim of this study was to develop 
recombinant strains of S. peucetius which are 
improved DXR production by the genetic 
engineering dnrS/dnrQ. The genes were cloned and 
expressed in the S. peucetius host cells. The 
screening process is to better understand that the 
dnrQ and dnrS works as regulation role for higher 
amount of DXR and the selection the engineered S. 
peucetius as potentical candidate used in the 
production on scale.  
MATERIALS AND METHODS 
Materials  
 DXR standard was provided by the Genechem 
Co. (Daejeon, Korea). HPLC grade methanol was 
acquired from Mallinckrodt Baker (Phillipsburg, NJ, 
USA). The PCR premix (Genotech, Korea) was used 
for the preliminary screening or optimizing the PCR 
conditions. Glucose, 22.5 g; Difco yeast extract, 5.04 
g; NaNO3, 4.28 g; K2HPO4, 0.23 g; HEPES, 4.77 g; 
MgSO4.7H2O, 0.12 g; NaOH, 0.4 g; trace element 
solution; PEG, thiostrepton antibiotics, and other 
chemicals for experiment were purchased from 
Sigma Co. Ltd.  S. peucetius MH9.2, S.peucetius 
wild strains supported from the Central of Research 
and Applied Biotechnology, Ha Noi Open University 
was used as a parental strain. 
Methods 
DNA manipulation, gene cloning and polymerase 
chain reaction (PCR) 
 Standard methods were used for DNA cloning, 
plasmid isolation, and restriction enzyme digestion 
followed by Kieser’s protocol (Kieser et al., 2000). 
The nucleotide sequences were analysed by using 
DNA strider. Potential open reading frames (ORFs) 
were identified using Frame Plot (Sambrook et al., 
2001), and were searched for homologies using 
NCBI BLAST server 
(www.ncbi.nlm.nih.gov/BLAST/).  
 Oligonucleotide primers for the amplification of 
desired ORFs using a thermo cycler (Takara) used in 
this study are summarized in Table 1. The reaction 
mixture contained 20 pM primers, 0.125 mM 
deoxynucleotide triphosphates (dNTPs), 10% 
dimethyl sulfoxide (DMSO), appropriate amount of 
template DNA, 2 unit of La Taq polymerase, 2.5 
mM MgCl2, in the PCR buffer supplied with 
enzyme. The PCR conditions: denaturation 
temperature at 94ºC for 7 min then followed by 30 
cycles of 94ºC for 1 min, annealing temperature 
Figure 1 The mechanism of dnrQ/S activity in the biosynthesis of DXR. 
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range from 55ºC to 68ºC for 1 min depending upon 
the PCR primers and the template and 72ºC for 1 
min; and 72ºC for 10 min for the last extension 
cycle.  
 
Table 1. Primers for PCR.  
Name Sequence Restriction site 
dnrQ-F 5’- GAATTCGTGTGAGGAGCACGACG -3’   EcoRI 
dnrQ-R 5’-GGATCCGGTCACCCTCCCTGGG -3’ BamHI 
dnrS-F 5’- CTGCAGCAGGGAGGGTGACCCC -3’ PstI 
dnrS-R 5’-AAGCTTATCCAAACGAAAGCCC- 3’ HindIII 
 
Construction of expression plasmid p25.1SQ  
Isolation and purification of dnrS and dnrQ  
 To amplify the dnrS (1296 bp) and dnrQ (1317 
bp) from S. peucetius genomic DNA, the PCR 
process was carried out as protocol described above. 
The primers dnrQ-F/dnrQ-R were used for cloning 
dnrQ; dnrS-F/dnrS-R used for cloning dnrS gene. 
The PCR products of dnrQ and dnrS were digested 
by EcoRI/BamHI and PstI/HindIII respectively, 
which were then cloned into the cloning vector with 
high copy number, namely, pGEM-3Z(+) producing 
the pGEM-QS vector containing dnrQS fragment for 
the further other analysis and experiments. All of the 
PCR products were cloned into pGEM-T vector 
(Promega, USA) and sequenced prior to cloning into 
the expression vector to verify that no mutations had 
been introduced during the PCR amplification. 
Cloning dnrS and dnrQ into p25.1 vector 
 Originally, the transformation into Streptomyces 
cell has been challenged many research groups, so 
iBR25 vector was constructed as a special vector 
used to transform into Steptomyces cells (the size 
7.5kb). Vector modified p25.1 (9.7kb) has been 
completely created which is bared desIII and desIV 
genes form S. venezuela genome and strong 
promotor isolated from Erythromycin gene cluster. 
The desIII and desIV genes are functioned as 
participating in the deoxysugar biosynthesis of 
antibiotics and increasing the antibiotic 
biosynthesis production (Thuy et al., 2014). 
Protoplast transformation and screening 
 For protoplast transformation, regeneration, 
and DNA transformation were slightly modified 
from the methods of Kieser et al. (2000) and 
followed by Sailesh’s protocol (Sailesh et al., 
2010). S. peucetius was grown in a 500 ml baffled 
flask containing 50 ml R2YE medium at 28°C for 
48 – 60 hrs. Mycelia were harvested by 
centrifugation and washed with 10.3% sucrose 
then with P-buffer. The protoplast and mycelia 
mixture were filtered through cotton plug to 
remove cell debris. The protoplasts were gathered 
by centrifugation and washed twice with P-buffer. 
A 125 µl of protoplasts were treated with 0.1 mM 
aurintricarboxylic acid (ATA) for 10 min and 12 
µl to 15 µl of plasmid DNA was added. 
Immediately, 200 µl of 40% (wt/vol) polyethylene 
glycol 1000 (PEG) solution was added and then, 
centrifuged briefly to remove PEG. These 
transformed protoplasts were plated in R2YE 
regeneration plate, and was incubated at 28°C for 
24 hrs. The lawn colonies were overlaid by 0.3% 
agar solution containing appropriate antibiotics 
(20 - 100 µg ml-1 thiostrepton). After overlaying, 
selected colonies were screened on growing media 
with antibiotics as per the required condition. 
Production of DRX by engineered strain 
 The S. peucetius engineered strains were 
inoculated into 50 ml NDYE-glucose medium [(per 
liter) glucose 22.5 g; Difco yeast extract 5.04 g; 
NaNO3 4.28 g; K2HPO4  0.23 g; HEPES 4.77 g; 
MgSO4·7H2O, 0.12 g; NaOH 0.4 g; and trace element 
solution, 2 ml] at 28°C and 230 rpm. After 48 h of 
incubation, 1 ml of seed culture was transferred to 50 
ml of NDYE-maltose medium, which comprises of 
(per liter) Difco maltose, 22.5 g instead of glucose in 
NDYE-glucose medium. The incubation was carried 
out at 28°C and 230 rpm for 5 days. 
Isolation of doxorubicin from fermentation broth 
 Aliquots of culture broth containing mycelia 
were extracted with twice volume of chloroform-
methanol (9:1) (Parajuli et al., 2005). The extracted 
solvents were evaporated until dryness by the 
method of rotary evaporator. Thus obtained residue 
extract was reconstituted in 1 ml of methanol and 
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subsequently subjected to HPLC and LC-MS 
analysis. For the comparison of DXR production, 1 
ml culture media of broth strains were extracted with 
double volume of the mixture of chloroform: 
methanol (9:1) after 84, and 96 h of incubation. The 
extraction-solvent was evaporated in vacuumm and 
dissolved in 50 μl of methanol. A 15- 20µl sample of 
the extract was injected to HPLC. 
 
Analysis of DXR production 
 The HPLC analyses were performed by injecting 
15 μl of extracts sample fitted with a Mightysil RP-
18 GP column (4.6 x 250nm x 5 μm, Kanto 
Chemical Tokyo). The elution was carried out with 
water (at pH 2.3 by trifluoro acetic acid) at the flow 
rate of 1 ml min-1 by the following method: 0-50 min 
(0-100% B), 50-60 min (100% B) and 60-70 min 
(100% A). Detection was carried out by UV light 
absorption at 254 nm wavelengths. Authentic DXR 
and DNR were taken as reference. 
 The HPLC standard cover of doxorubicin was 
used for the quantity analysis which was set up with 
the range of doxorubicin concentration from the 100, 
200, 300, 400, and 500 µg.ml-1 (Table 2).  
 
Antibacterial assay  
 Bacillus subtilis was used for test of antibacterial 
activity. Specifically, 5 μl aliquots of the 
chloroform-methanol whole-cell extracts were added 
to paper discs and placed on a lawn of test strain (B. 
subtilis) overlaid onto nutrient agar plates. The plates 
were incubated at 37°C overnight. The antibacterial 
activity of the secondary metabolites was observed 
by the appearance of the diameter of clear inhibition 
zones surrounding the paper disc. Methanol was 
used as negative control.  
 
Table 2.  Concentration of doxorubicin for the standard 
cover for HPLC analysis. 







RESULTS AND DISCUSSION 
Isolation and sequence analysis of dnrS and dnrQ  
  The dnrS and dnrQ genes were amplified by the 
PCR method as described in the protocol above 
(Materials and Method). All of the PCR products 
were cloned into pGEM-T vector (Promega, USA) 
and sequenced prior to cloning into the expression 
vector to verify that no mutation had been introduced 
during the PCR amplification. The open reading 
frame dnrQ (1,317 bp) flanked by dnrS (1,296 bp) 
are located within the doxorubicin biosynthesis gene 
cluster downstream of the polyketide synthase (PKS) 
genes. The dnrQ and dnrS genes were flanked 
upstream by dnrP and downstream by dnrC. Using 
the ClustalW program, the determined sequence 
analysis of these genes revealed a deduced amino 
acid sequence of dnrS (432 aa) that encodes 
glycosyltransferase and showed a very high degree 
of similarity to a number of the known GTs in the 
GenBank, including GT from Streptomyces 
prasinopilosus (94% identity) (GenBank accession 
no. WP_055571862.1); glycosyltranferase from 
Streptomyces sp. ScaeMP-e83 (87% identiy) 
(GenBank accession no WP_093692494.1); and GT 
from Streptomyces kasugaensis (61% identity) 
(GenBank accession WP_094791596.1). In addition, 
analysis of the amino acid sequences of dnrQ 
encoded for the auxilary protein to help the activity 
of dnrS (Singh et al., 2010) that show high similarity 
to protein helper of Streptomyces prasinopilosus 
(GenBank Accession no. WP-055693204.1); 
activator protein from Streptomyces sp. ScaeMP-e83 
(GenBank accession no. WP_093692495.1). 
Construction of expression plasmid p25.1SQ  
 To construct recombinant expression plasmid, 
the 2.5 kb DNA fragment containing the dnrSQ was 
digested by EcoRI/HindIII from the pGEM-SQ 
vector and the cloned into modified p25.1 vector 
digested with the same restriction enzymes as well as 
by the ligation reaction.  
 The screening process was carried out by the 
transformation of ligation mixture into E.coli XL-
blue and growing in the Apramycin antibiotic 
medium for the selection of correct colonies which 
are bearing the expression plasmid containing dnrQS 
fragment named p25.1SQ. Finally, the obtained 
recombinant expression plasmid p25.1SQ was 
examined for the correct clone by restriction enzyme 
digestion (EcoRI/HindIII). The bands of DNA 
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running in the agarose electrophoresis have shown 
the correct clone of the dnrQS (2.6 kb) into the 
expression plasmid (9.7 kb). 
The appropriated conditions for transformation 
of p25.1.SQ into S. peucetius MH9.2 
 The plasmid was firstly propagated into E. coli 
ET-12567 host to get demethylated plasmid DNA 
and to get of risk the degradation of foreigner DNA. 
Then isolated plasmid from E. coli ET was 
transformed into S. peucetius MH9.2 host by using 
PEG-mediated protoplast transformation. For 
screening process, the transformed protoplast 
mixture was plated onto the R2YE medium. The 
plates were overlaying with 20 - 1000 µg.ml-1 
thiostrepton (tsr) after exactly 20 hrs of inoculation. 
The correct recombinant strains which is harbored
the expression plasmids named as S. peucetius 
MH9.2QS) were selected by showing growing and 
resistant thiostreptone resistance.    
 The factors, have effects on the transformation 
yield, include concentration of PEG, the time period 
for lysozyme inoculation and thiostreptone antibiotic 
overlaying after transformation.  The results have 
shown that there was very high growth rate but no 
transformation occurred if the antibiotic, PEG and 
lysozyme were applied at very low concentration. In 
contrast, all cell deaths were observed when those 
condition and concentration increased. The best 
condition for transformation was discovered for 
recombinant strain including 80 mg.mg-1 tsr, 40% 
v.v PEG and lysozyme inoculation for 50 min, 
respectively (Table 3). 
 
 
Table 3. Selection of condition for transformation of the p25.1SQ plasmid into S. peucetius MH9.2. 
 















Growth of transformed colonies 
50 ++ 10 -  30 High growth rate 
No transformation occurred 
60 + 20 -  40 High growth rate 
No transformation occurred 
70 - 30 + 50 Normal growth rate 
Transformation successes 
80 - 40 ++ 60 Very low growth rate 
Transformation successes 
90 - 50 - 70 Death cell 




Antibacterial bioassay and thin layer 
chromatography (TLC) of doxorubicin 
 For the preliminary analysis of production 
from recombinant strain, the fermentation of the 
recombinant was carried out for 84 hrs and the 
host strain as control sample was culture for 60 
hrs, 72 hrs, 84 hrs and 96 hrs, respectively. The 
solvent system of CHCl3:MeOH was applied to 
the whole cell extracts, then extraction was
centrifuged to remove the medium and collect the 
solvent containing crude doxorubicin extraction. 
The TLC and bioassays analysis were performed. 
TLC analysis indicated that S. peucetius p25.1 QS 
produced doxorubicin compound in higher amount 
in comparison with the S. peucetius MH9.2 (Fig. 
2B). Similarly the bioactivity test of the 
compounds indicated the greater inhibition zone in 
case of S. peucetius 25QS than S. peucetius 





























Analysis of DXR production from engineered 
strain  
 To test the level accumulation of doxorubicin, 
four colonies of S. peucetius MH9.2QS recombinant 
strains and MH9.2 as control strain were selected for 
analysis and measuring DXR production. The 
fermentation of strains in the production medium 
(NDYE) were carried out for biomasses of both 
recombinant and parental strains.  
 The HPLC and LC-mass analysis of the isolated 
doxorubicin product from the recombinant strain 
have shown the significant amount increased more 
than three times in comparison with parental strains.  
HPLC profile showed the compound having 
molecular ion with peak at a retention time of 32.5  
min in HPLC (Figs. 3A, 3B, 3C). The amount of 
doxorubicin produced by recombinant strains, which 
were calculated in the biomass fermentation, was 
from 6.8 to 7.25 mg.l-1. Meanwhile the amount 
produced by the parental strain was only 2.3 mg.l-1 
(Table 4). 
 Profile with m/z = 544.6 [M+H+] in LC-ESI/MS 
analysis which corresponded to DXR (calculated 
mass 543.53). Identification of DXR was also 
verified by comparison with standard (Figs. 4A, 4B). 
The results indicated that the DXR productivity was 
enhanced more by over expression of the cognate 
GT pairing of dnrS/dnrQ in the host strain S. 
peucetius. The recombinant strain could be potential 
for the other phase research.  
 
Table 4. Production analysis by HPLC of the recombinant strains. 
Name Y X Yields  (µg.ml-1) 
S. peucetius MH9.2 335994 5,84342692 2,337371 
S. pMH9.2QS02 887320 17,76811437 7,107246 
S. pMH9.2QS05 901007 18,06415192 7,225661 
S.p MH9.2QS03 852834 17,02221309 6,808885 








DXR A B C D E
B 
Figure 2. A: Antibacterial assay of extracted compound from S. peucetius against B. subtilis;  B: TLC of total anthracycline 
chloroform:methanol:acetic acid (9:1:1); DXR: doxorubicin standard; A crude from the recombinant strain S.p25.1QS); 
C,D,B,E crude extract from S.MH9.2 isolated after 60, 72, 84 and 96 hrs fermentation. 
 



























































Figure (3). HPLC chromatograms of extracted doxorubicin from S. peucetius, perantal and recombinant strains. (A) Standard 
DXR, (B) S. peucetius MH9.2, C) S. peucetius 25.1MH9.2SQ, 

























 Over production of doxorubicin from 
recombinant strain by genetically engineering, in 
which the dnrQ and dnrS genes were cloned into 
p25.1 and then transformed into the host S. peucetius 
MH9.2, has given the significant effect on DXR 
biosynthesis. The production of DXR was enhanced 
up to 7.3 mg l-1 (3.5 folds if compared to parental 
strain) whereas, the parental strain produced 2.2 mg 
l-1. The strain S.p.MH9.2QS has the higher titers of 
DXR because of higher TDP-L-daunosamine pool 
and efficient glycosylation and to reduce the toxic 
nature of DXR against cell itself.  
Acknowledgement: The work was supported by 
Ministry of Industry and Trade Vietnam, funded by 
National Key Research Program on Industrial 
Development of Pharmaceutical Chemistry “Chương 
trình nghiên cứu trọng điểm cấp nhà nước – Chương 
trình Hoá dược” Granted Number: 069/2016/HĐ-
ĐT.CNHD. 
REFERENCES 
Arcamone F, Animati F, Capranico G, Lombardi P, Pratesi 
G, Manzini S, Supino R, Zunino F (1997) New 
developments in antitumor anthracyclines. Pharmacol 
Ther 76: 117–124. 
Chater KF, Bibb MJ. In: Kleinkauf H, von Döhren H 
(Eds.) (1996) Biotechnology: Products of Secondary 
Metabolism 7: 57–105. Wiley–VCH, Weinheim.  
Dreier J, Khosla C (2000) Mechanistic analysis of a type II 
polyketide synthase. Role of conserved residues in the 
beta-ketoacyl synthase-chain length factor heterodimer. 
Biochem 39 (8): 2088–95 Promega. 
Fernández-Moreno MA, Caballero JL, Hopwood DA, 
Malpartida F (1991) The act cluster contains regulatory 
and antibiotic export genes, direct targets for translational 
control by the bldA tRNA gene of Streptomyces. Cell 66: 
769–780.  
Hung TV, Malla S, Park BC, Liou K, Lee HC, Sohng JK 
(2007) Enhancement of clavulanic acid by replicative and 
integrative expression of ccaR and cas2 in Streptomyces 
clavuligerus NRRL3585. J Microbiol Biotechnol 17: 
1538–1545. 
Jiang H, Hutchinson CR (2006) Feedback regulation of 
doxorubicin biosynthesis in Streptomyces peucetius. Res 
Microbiol 157 (7): 666–674. 
Kieser T, Bibb, MJ, Buttner, MJ, Chater, KF, Hopwood 
DA (2000) Practical Streptomyces genetics. The John 
Innes Foundation Norwich, pp. 412. 
Liu W, Leimkuhler C, Gatto GJ, Jr Kruger RG, Oberthür 
M, Kahne D, Walsh CT (2005) AknT is an activating 
protein for the glycosyltransferase AknS in L-
aminodeoxysugar transfer to the aglycone of 
aclacinomycin A. Chem Biol 12: 527–534. 
Figure 4.  ESI-mass analysis of the doxorubicin standard in positive mode with the molecular weight (mz +) 554.6;  (A) DXR 
standard (B) S. peucetius 25.1MH9.2QS. 
Tạp chí Công nghệ Sinh học 15(1): 151-159, 2017 
 
159 
Mallar S, Niraula NP, Singh B, Liou K, Sohng JK (2010) 
Limitations in   doxorubicin production from Streptomyces 
peucetius. Microbiol Res 165 (5): 427–435.  
Narva KE, Feitelson JS (1990) Nucleotide sequence and 
transcriptional analysis of the redD locus of Streptomyces 
coelicolor A3(2)  J Bacteriol 172: 326–333.  
Parajuli N, Hung TV, Ishida K, Tong HT, Lee HC, Liou K, 
Sohng JK (2005) Identification and characterization of the 
afsR homologue regulatory gene from Streptomyces 
peucetius ATCC 27952. Res Microbiol 156: 707–712. 
Mallar S, Narayan PN, Liou K, Sohng JK (2009) 
Enhancement of doxorubicin production by expression of 
structural sugar biosynthesis and glycosyltransferase genes 
in Streptomyces peucetius. J Biosci Bioeng 108(2): 92–98. 
Sailesh M, Narayan PN, Liou K, Sohng JK (2010) 
Microbiol Res 165 (4): 259–267. 
Sambrook J, Russell DW (2001) Molecular cloning, a 
laboratory manual 3rd edition, Cold Spring Harbor 
Laboratory Press, Cold Spring Harbor NY. 
Sharee LO, Xiaochun L, Jan FC, Hutchinson CR (1995) 
Cloning and characterization of the Streptomyces peucetius 
dnrQS genes encoding a daunosamine biosynthesis 
enzyme and a glycosyl transferase involved in 
daunorubicin biosynthesis. J Bacteriol 177(22): 6688–
6692. 
Singh B, Lee CB, Sohng JK (2010) Precursor for 
biosynthesis of sugar moiety of doxorubicin depends on 
rhamnose biosynthetic pathway in Streptomyces peucetius 
ATCC 27952. Appl Microbiol Biotechnol 85(5): 1565–
1574.  
Thủy TT, Chung NT (2014) Design the special vector used 
for Streptomyces producer of regulation of antibiotic 
production. Sci Tech HOU 4: 45. 
 
BIẾN NẠP GENE GLYCOSYLTRANSFERASE DNRS VÀ GEN HỖ TRỢ DNRQ VÀO TẾ 
BÀO STREPTOMYCES PEUCETIUS MH9.2 LÀM TĂNG KHẢ NĂNG TỔNG HỢP 
DOXORUBICIN  
  
Ta Thi Thu Thủy1, Nguyễn Huy Hoàng2 
1Viện Đại học Mở Hà Nội  
2Viện Nghiên cứu hệ gen, Viện Hàn lâm Khoa học và Công nghệ Việt Nam 
TÓM TẮT 
 Doxorubicin (DXR) là kháng sinh quan trọng được sử dụng điều trị ung thư, được sinh tổng hợp bởi 
Streptomyces peucetius. Quá trình sản xuất doxorubicin bằng phương pháp lên men từ chủng vi sinh vật gốc 
thường thu được hiệu suất thấp. Có nhiều nhóm nghiên cứu đã và đang tập trung nghiên cứu để làm tăng khả 
năng sinh tổng hợp doxorubicin từ chủng gốc bằng kỹ thuật tách dòng, biểu hiện nhóm gen hỗ trợ và điều hòa 
của chủng gốc. Nhóm gen dnrQ và dnrS tham gia con đường sinh tổng hợp doxorubicin có chức năng là vận 
chuyển gốc đường khử dnrS, và gen hỗ trợ đi kèm là dnrQ hay còn được gọi là gen điều hòa. Nhóm gen 
dnrS/Q được tách dòng và sau đó được chuyển vào vector p25.1 có mang promoter mạnh (ermE*). Vector này 
được biến nạp chuyển vào chủng gốc S. peucetius MH9.2  bằng phương pháp tế bào trần đã tạo được chủng tái 
tổ hợp S. peucetius MH9.2SQ.  Khả năng sinh tổng hợp doxorubicin từ chủng tái tổ hợp đã tăng vượt trội từ 
3,1 đến 3,6 lần so với chủng gốc ban đầu. Các kết quả được khẳng định bằng phương pháp phân tích sắc ký 
lỏng cao áp (HPLC), sắc ký lỏng khối phổ (LC-mass) và đánh giá sinh học. Kết quả này cho thấy chủng tái tổ 
hợp là tiềm năng ứng dụng cho các nghiên cứu tiếp theo để tạo sản phẩm doxorubicin với qui mô lớn hơn.  
Từ khóa: chủng tái tổ hợp di truyền, sinh tổng hợp Doxorubicin, Streptomyces peucetius, tách dòng gene.   
 
